Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
Titel:
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
Auteur:
Cudkowicz, Merit Genge, Angela Maragakis, Nicholas Petri, Susanne van den Berg, Leonard Aho, Valtteri V Sarapohja, Toni Kuoppamäki, Mikko Garratt, Chris Al-Chalabi, Ammar